Reference
Ahmed, D., Kumar, V., Sharma, M., and Verma, A. (2014a). Target guided isolation, in-vitro antidiabetic, antioxidant activity and molecular docking studies of some flavonoids from Albizzia Lebbeck Benth. bark. BMC Complement. Altern. Med. 14 : 155.
Ahmed, D., Kumar, V., Sharma, M., and Verma, A. (2014b). Target guided isolation, in-vitro antidiabetic, antioxidant activity and molecular docking studies of some flavonoids from Albizzia Lebbeck Benth. bark. BMC Complement. Altern. Med. 14 : 155.
Ahmed, D., Kumar, V., Verma, A., Gupta, P.S., Kumar, H., Dhingra, V., et al. (2014c). Antidiabetic, renal/hepatic/pancreas/cardiac protective and antioxidant potential of methanol/dichloromethane extract of Albizzia Lebbeck Benth. stem bark (ALEx) on streptozotocin induced diabetic rats. BMC Complement. Altern. Med. 14 : 243.
Ahmed, D., Kumar, V., Verma, A., Shukla, G.S., and Sharma, M. (2015). Antidiabetic, antioxidant, antihyperlipidemic effect of extract of Euryale ferox salisb. with enhanced histopathology of pancreas, liver and kidney in streptozotocin induced diabetic rats. Springerplus4 : 315.
Ahmed, D., Sharma, M., Mukerjee, A., Ramteke, P.W., and Kumar, V. (2013). Improved glycemic control, pancreas protective and hepatoprotective effect by traditional poly-herbal formulation ‘Qurs Tabasheer’ in streptozotocin induced diabetic rats. BMC Complement. Altern. Med. 13 : 10.
Alipio, Z., Liao, W., Roemer, E.J., Waner, M., Fink, L.M., Ward, D.C., et al. (2010). Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc. Natl. Acad. Sci. U. S. A. 107 : 13426–13431.
Bisht, R., Bhattacharya, S., Jaliwala, Y.A., Chatterjee, C., Auddy, S., Chaudhuri, S., et al. (2010). Indian Medicinal Plants. Der Pharm. Sin.2 : 1176–1181.
Chen, Y.Z., and Zhi, D.G. (2001). Ligand - Protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins Struct. Funct. Genet. 43 : 217–226.
Chyan, Y. (2007). Dipeptidyl Peptidase-IV Inhibitors: An evolving treatment for type 2 diabetes from the incretin concept. Recent Pat. Endocr. Metab. Immune Drug Discov. 1 : 15–24.
Drouin, P., Blickle, J.F., Charbonnel, B., Eschwege, E., Guillausseau, P.J., Plouin, P.F., et al. (2009). Diagnosis and classification of diabetes mellitus. Diabetes Care 32 : S62–S67.
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., et al. (2002). Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 106 : 2067–2072.
Geethan, P.K.M.A., and Prince, P.S.M. (2008). Antihyperlipidemic effect of D-pinitol on streptozotocin-induced diabetic wistar rats. J. Biochem. Mol. Toxicol. 22 : 220–224.
Giacco, F., and Brownlee, M. (2010). Oxidative stress and diabetic complications. Circ. Res. 107 : 1058–1070.
Gray, J.J., Moughon, S., Wang, C., Schueler-Furman, O., Kuhlman, B., Rohl, C.A., et al. (2003). Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations. J. Mol. Biol. 331 : 281–299.
Gupta, R., Walunj, S.S., Tokala, R.K., Parsa, K.V.L., Singh, S.K., and Pal, M. (2009). Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of Type 2 Diabetes. Curr. Drug Targets 10 : 71–87.
Kavishankar, G., Lakshmedevi, N., Murthy, S.M., Prakash, H., and Niranjana, S. (2011). Diabetes and Medicinal plants – A review. Int J Pharm Biomed Sci 2 : 65–80.
Kumar, V., Ahmed, D., Verma, A., Anwar, F., Ali, M., and Mujeeb, M. (2013). Umbelliferone β-D-galactopyranoside from Aegle marmelos (L.) corr. an ethnomedicinal plant with antidiabetic, antihyperlipidemic and antioxidative activity. BMC Complement. Altern. Med. 13 : 273.
Kumar, V., Anwar, F., Ahmed, D., Verma, A., Ahmed, A., Damanhouri, Z. a, et al. (2014). Paederia foetida Linn. leaf extract: an antihyperlipidemic, antihyperglycaemic and antioxidant activity. BMC Complement. Altern. Med. 14 : 76.
Lamont, B.J., and Drucker, D.J. (2008). Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat-fed mice. Diabetes 57 : 190–198.
Lionetti, L., Mollica, M.P., Lombardi, A., Cavaliere, G., Gifuni, G., and Barletta, A. (2009). From chronic overnutrition to insulin resistance: The role of fat-storing capacity and inflammation. Nutr. Metab. Cardiovasc. Dis. 19 : 146–152.
Lordan, S., Smyth, T.J., Soler-Vila, A., Stanton, C., and Paul Ross, R. (2013). The α-amylase and α-glucosidase inhibitory effects of Irish seaweed extracts. Food Chem. 141 : 2170–2176.
Meier, J.J. (2012). GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat. Rev. Endocrinol. 8 : 728–742.
Newsholme, E. a, Rolleston, F.S., and Taylor, K. (1968). Factors affecting the glucose 6-phosphate inhibition of hexokinase from cerebral cortex tissue of the guinea pig. Biochem. J. 106 : 193–201.
Pandey, P., Bhatt, P.C., Rahman, M., Patel, D.K., Anwar, F., Al-Abbasi, F., et al. (2017). Preclinical renal chemo-protective potential ofPrunus amygdalus Batsch seed coat via alteration of multiple molecular pathways. Arch. Physiol. Biochem. 3455 : 1–9.
Pannala, R., Leirness, J.B., Bamlet, W.R., Basu, A., Petersen, G.M., and Chari, S.T. (2008). Prevalence and Clinical Profile of Pancreatic Cancer-Associated Diabetes Mellitus. Gastroenterology 134 : 981–987.
Perić-Hassler, L., Hansen, H.S., Baron, R., and Hünenberger, P.H. (2010). Conformational properties of glucose-based disaccharides investigated using molecular dynamics simulations with local elevation umbrella sampling. Carbohydr. Res. 345 : 1781–1801.
Rains, J.L., and Jain, S.K. (2011). Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med. 50 : 567–575.
Ramachandran, A., Snehalatha, C., Shetty, A.S., and Nanditha, A. (2012). Trends in prevalence of diabetes in Asian countries. World J. Diabetes3 : 110–117.
Rolo, A.P., and Palmeira, C.M. (2006). Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 212 : 167–178.
Rubin, R.R. (2005). Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am. J. Med. 118 Suppl : 27S-34S.
Sang, S., Lapsley, K., Jeong, W.S., Lachance, P.A., Ho, C.T., and Rosen, R.T. (2002). Antioxidative phenolic compounds isolated from almond skins (Prunus amygdalus Batsch). J. Agric. Food Chem. 50 : 2459–2463.
Seino, Y., Fukushima, M., and Yabe, D. (2010). GIP and GLP-1, the two incretin hormones: Similarities and differences. J. Diabetes Investig.1 : 8–23.
Shaw, J.E., Sicree, R.A., and Zimmet, P.Z. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract.87 : 4–14.
Szkudelski, T. (2012). Streptozotocin–nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp. Biol. Med.237 : 481–490.
Takahashi, S., Sakai, J., Fujino, T., Hattori, H., Zenimaru, Y., Suzuki, J., et al. (2004). The Very Low-density Lipoprotein (VLDL) Receptor: Characterization and Functions as a Peripheral Lipoprotein Receptor. J Atheroscler.Thromb 11 : 200–208.
Tappy, L., and Lê, K.A. (2012). Does fructose consumption contribute to non-alcoholic fatty liver disease? Clin. Res. Hepatol. Gastroenterol.36 : 554–560.
Toma, A., Makonnen, E., Mekonnen, Y., Debella, A., and Addisakwattana, S. (2014). Intestinal α-glucosidase and some pancreatic enzymes inhibitory effect of hydroalcholic extract of Moringa stenopetala leaves. BMC Complement. Altern. Med. 14 : 180.
Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T.D., Mazur, M., and Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol.39 : 44–84.
Wang, C.P., Li, J.L., Zhang, L.Z., Zhang, X.C., Yu, S., Liang, X.M., et al. (2013). Isoquercetin protects cortical neurons from oxygen-glucose deprivation-reperfusion induced injury via suppression of TLR4-NF-kB signal pathway. Neurochem. Int.